Please login to the form below

Not currently logged in
Email:
Password:

Immunicom

This page shows the latest Immunicom news and features for those working in and with pharma, biotech and healthcare.

Breakthrough Device status for novel blood filtering immunotherapy

Breakthrough Device status for novel blood filtering immunotherapy

The process is based  on a proprietary recombinant protein initially developed at University of Stuttgart from which Immunicom has licensed the worldwide exclusive rights. ... Immunicom's therapeutic approach is still very much in its early stages, the

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Genesis Research

Genesis Research is an international HEOR and RWE research organization. A leader in evidence strategy, generation and communication, the company...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...